drugset / Trial / NCT05057117

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

NCT05057117

Phase 4 Completed 30 enrolled Merete Haedersdal
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial aims is to assess and compare treatment effect of microwave thermolysis and botulinum toxin A for axillary hyperhidrosis with focus on longevity. The investigators also aim to assess patient satisfaction and adverse reactions in relation to treatment.

Timeline

Start
2021-09-27
Primary completion
2022-10-17
Completion
2023-04-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 50 iu
Comparator Botulinum toxin type A Protein / enzyme biologic 100 iu